(Q41005869)

25 September 2017

Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma (English)

1 reference

25 September 2017

Ong C

1

1 reference

25 September 2017

Wong C

2

1 reference

25 September 2017

Roberts CR

3

1 reference

25 September 2017

Teh HS

4

1 reference

25 September 2017

Jirik FR

5

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

European Journal of Immunology

25 September 2017

1 reference

25 September 2017

28

1 reference

25 September 2017

2619-2629

1 reference

25 September 2017

9

1 reference

Tight-skin mouse an experimental model for scleroderma

25 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Lymphocyte responses and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Acquisition of lymphokine-producing phenotype by CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Interleukin 4 expressed in situ selectively alters thymocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Cloning and analysis of murine cDNA that encodes a fibrogenic lymphokine, fibrosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

The mechanism of autoantibody formation to cartilage in rheumatoid arthritis: possible cross-reaction of antibodies to dietary collagens with autologous type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199809%2928%3A09%3C2619%3A%3AAID-IMMU2619%3E3.0.CO%3B2-M

10.1002/(SICI)1521-4141(199809)28:09<2619::AID-IMMU2619>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference